Metabolomics in degenerative brain diseases
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1773, 147704
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using MetabolomicsPLOS ONE, 2013
- Alterations in metabolic pathways and networks in Alzheimer’s diseaseTranslational Psychiatry, 2013
- Metabolite identification and quantitation in LC-MS/MS-based metabolomicsTrAC Trends in Analytical Chemistry, 2012
- Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopyChemical Society Reviews, 2011
- Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Alterations of the Sphingolipid Pathway in Alzheimer’s Disease: New Biomarkers and Treatment Targets?NeuroMolecular Medicine, 2010
- 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancerBritish Journal of Cancer, 2010
- The relationship between uric acid levels and Huntington's disease progressionMovement Disorders, 2010
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson DiseaseArchives of Neurology, 2009
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003